CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Sarcoidosis Patient Assessment and Resource Companion App +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05230693
NCT05230693N/ACompleted

The SPARC App: A Smartphone Application for the Management of Sarcoidosis-Associated Fatigue

Medical University of South Carolina·interventional·Posted Feb 9, 2022·Updated Apr 6, 2025

In Brief

A clinical study evaluating Sarcoidosis Patient Assessment and Resource Companion App and Enhanced Standard Care for Sarcoidosis and Fatigue. Completed, enrolled 50 participants across 1 site.

Detailed Summary

Fatigue is a pervasive and disabling symptom in sarcoidosis with limited treatment options. There is a significant association between heightened stress and sarcoidosis-associated fatigue. The proposed project will evaluate the usability/feasibility of a smartphone-based stress management application for the self-management of sarcoidosis-associated stress and fatigue.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSarcoidosis, Fatigue
CountriesUnited States

Timeline

N/ACompletedFinished
20222023202420252026
First PostedFeb 9, 2022
Enrollment StartFeb 23, 2022
Primary CompletionDec 22, 2022
Study CompletionJul 25, 2023
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 4.4 years ago

Interventions

Sarcoidosis Patient Assessment and Resource Companion Appbehavioral

The first group, called the "SPARC group" will be asked to download the SPARC app onto the participant's smartphone, will be shown how to use the app, and then will be asked to use the app to do guided meditations for ten minutes twice a day

Enhanced Standard Carebehavioral

Participants will receive education about reducing fatigue associated with sarcoidosis during a normal clinic visit.